Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
30 August 2018 Photo Xolisa Mnukwa
Haemophilia workshop the first of its kind at UFS
The UFS Department of Haematology and Cell Biology is producing quality medical graduates, addressing the high demand for trained graduates. Dr Anneke van Marle, Haematologist in the department, presented a lecture to final-year medical students on muscle and soft-tissue bleeding in haemophilia.
The Medical and Scientific Advisory Council (MASAC) of the South African Haemophilia Foundation (SAHF) has identified a need for more in-depth training of junior doctors on the basic aspects of the bleeding disorder haemophilia. 

Addressing this need in the sector, the Department of Haematology and Cell Biology at the University of the Free State (UFS) recently hosted a training workshop specifically targeting final-year medical students before they enter practice.

The Novo Nordisk Haemophilia Foundation is sponsoring this countrywide haemophilia training.

According to Jaco Joubert, Senior Lecturer and Pathologist in the Department of Haematology and Cell Biology, the department is very active in the field of haemophilia treatment, research and training, with representation on the Executive Committee of the Medical and Scientific Advisory Council of the South African Haemophilia Foundation.

Function with confidence

“The UFS Department of Haematology and Cell Biology has taken a proactive approach, by being the first department in South Africa to offer this training course to final-year medical students at the UFS; an investment in the future. The department runs the Bloemfontein Haemophilia Treatment Centre – which is the main haemophilia treatment and referral centre for patients from the Free State and Northern Cape. It is therefore ideally positioned to offer such training to students,” said Joubert.

Proactive role

The training workshop empowered and equipped students with more extensive knowledge on the practical aspects of managing patients with haemophilia; the various treatment products currently available in South Africa and laboratory diagnostic approaches in complicated cases. “This will enable students to function with more confidence during their internship and community service years,” said Joubert. 

He believes a training workshop of this calibre showcases the proactive role the department and the university is taking in the advancement of haemophilia training in South Africa.

News Archive

HIV Cure – Just another fantasy?
2016-07-27

Description: HIV Cure – Just another fantasy? Tags: HIV Cure – Just another fantasy?

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.
Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at  Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept